TY - JOUR
T1 - Bronchial stump infiltration after lung cancer surgery. Retrospective study of a series of 2994 patients
AU - Fernández, Esther
AU - De Castro, Pedro López
AU - Astudillo, Julio
AU - Fernández-Llamazares, Jaume
AU - Duque, José Luis
AU - Encuentra, Ángel López
AU - Rami-Porta, Ramon
AU - Armengol, Antonio Cantó
AU - Casanova, Juan
AU - Mariñan, Manuel
AU - Cerezal, Jorge
AU - De La Rota, Antonio Fernández
AU - Arrabal, Ricardo
AU - Gimferrer, Joseph Ma
AU - Aragoneses, Federico González
AU - Mata, Nicolás Moreno
AU - Freixinet, Jorge
AU - Rodríguez-Suárez, Pedro
AU - Poyán, Nicolás Llobregat
AU - Mañez, Nuria
AU - Serra-Mitjans, Mireia
AU - De Nicolás, José Luis Martín
AU - Valentín, Nuria Novoa
AU - Rodríguez, Jesús
AU - García, Antonio José Torres
AU - Gómez, Ana
AU - De La Torre, Mercedes
AU - Ramos, Abel Sánchez Palencia
AU - Zafra, Javier Ruiz
AU - Ugarte, Andrés Varela
AU - García, Pablo Gámez
AU - Yat, Wah Pun
PY - 2009/8/1
Y1 - 2009/8/1
N2 - The incidence of lung cancer has been increasing in developed countries since the mid-1990s. The main objective of this study is to determine if bronquial stump infiltration can affect survival in patients with lung cancer. For this purpose, we differentiate between carcinoma 'in situ' and invasive carcinoma. We included patients suffering from non-small cell lung cancer who underwent thoracothomy as treatment. The total number of patients was 2994. In this study, 80 patients out of the 2994 had bronchial stump affection. Eight patients were excluded thus a total of 72 patients were included, 52 of them had carcinoma 'in situ' and 20 invasive carcinoma. The global survival was 25 months. Patients with carcinoma 'in situ' had a median survival of 25 months as opposed to 21 months in patients with invasive carcinoma. We only found statistical significance when we compared the histology with the type of bronchial stump infiltration. We did not observe statistical significance in survival between carcinoma 'in situ' and invasive carcinoma bronchial stump infiltration (P=0.094). The only survival predictor variable is histology (adenocarcinoma), P=0.0001.
AB - The incidence of lung cancer has been increasing in developed countries since the mid-1990s. The main objective of this study is to determine if bronquial stump infiltration can affect survival in patients with lung cancer. For this purpose, we differentiate between carcinoma 'in situ' and invasive carcinoma. We included patients suffering from non-small cell lung cancer who underwent thoracothomy as treatment. The total number of patients was 2994. In this study, 80 patients out of the 2994 had bronchial stump affection. Eight patients were excluded thus a total of 72 patients were included, 52 of them had carcinoma 'in situ' and 20 invasive carcinoma. The global survival was 25 months. Patients with carcinoma 'in situ' had a median survival of 25 months as opposed to 21 months in patients with invasive carcinoma. We only found statistical significance when we compared the histology with the type of bronchial stump infiltration. We did not observe statistical significance in survival between carcinoma 'in situ' and invasive carcinoma bronchial stump infiltration (P=0.094). The only survival predictor variable is histology (adenocarcinoma), P=0.0001.
KW - Carcinoma in situ
KW - Lung cancer
KW - Stump bronchial affection
UR - https://www.scopus.com/pages/publications/68049104139
U2 - 10.1510/icvts.2009.204784
DO - 10.1510/icvts.2009.204784
M3 - Article
SN - 1569-9293
VL - 9
SP - 182
EP - 186
JO - Interactive Cardiovascular and Thoracic Surgery
JF - Interactive Cardiovascular and Thoracic Surgery
IS - 2
ER -
ODG 3 – Bona salut i benestar